Skip to content

MSQ Surveillance

LAA

Laboratory Animal Allergy

Laboratory Animal Allergy affects 11-44% of exposed research workers, and 75% of institutions don't know their own rate. MSQ:LAA finds sensitization before it becomes occupational asthma.

Starting at

$59per completion

UNDERSTANDING

What is MSQ:LAA?

A specialized medical surveillance questionnaire designed to identify laboratory workers at risk from animal allergen exposure and prevent progression to permanent respiratory disability.

The definition

Laboratory Animal Allergy Medical Surveillance Questionnaire is an evidence-based assessment that evaluates research workers' exposure risks and early symptoms. Based on a 10-year national study of 58,224 laboratory workers co-authored by Dr. Martin, this surveillance identifies workers at risk before permanent damage occurs.

The purpose

To identify workers developing allergic sensitization before progression to occupational asthma and permanent disability

Who needs it

Laboratory workers with potential exposure to animal allergens in research, pharmaceutical, and biotechnology facilities

ON THE PLATFORM

How it works

The surveillance protocol from the national LAA study, delivered as a questionnaire workers finish in minutes.

Workers report animal contact, tasks, and early symptoms through a questionnaire built on the 10-year national study of 58,224 laboratory workers that Dr. Martin co-authored. His team reviews the results and flags sensitization early, while intervention can still prevent progression to occupational asthma. Your institution finally learns its actual LAA rate instead of guessing.

COMPLIANCE

What compliance rests on

There is no LAA-specific OSHA standard. Protection runs on the General Duty Clause and the 1998 NIOSH Alert, and an institution's defense is a surveillance program it can document.

01

OSHA General Duty Clause applies

General Duty

Without specific LAA standards, employers must prove they're following evidence-based practices to protect workers

The requirement

Employers must provide a workplace "free from recognized hazards" that could cause death or serious physical harm, including known occupational allergens like laboratory animal proteins.

Proxima solution

MSQ:LAA surveillance demonstrates proactive hazard recognition and worker protection, providing regulatory defense through documented due diligence.

02

NIOSH Alert 1998

NIOSH Alert

Establishes federal recognition of LAA as significant occupational hazard requiring proactive protection

The requirement

NIOSH recommends comprehensive programs including medical surveillance to prevent asthma associated with laboratory animal work.

Proxima solution

Our platform incorporates NIOSH Alert recommendations with Dr. Martin's latest research for comprehensive surveillance protocols.

03

Research-backed standards

Evidence Base

Provides scientific foundation for surveillance protocols that demonstrably protect worker health

The requirement

Research co-authored by Dr. Martin shows comprehensive programs can reduce sensitization from 25.6% to 8.2%, with mandatory respiratory protection achieving near-zero symptomatic allergies.

Proxima solution

Platform incorporates proven prevention strategies from peer-reviewed research, including optimal surveillance timing and risk stratification.

MEDICAL PROCESS

Medical surveillance process

Occupational immunology, applied by the physician who co-wrote the national LAA study.

Dr. Bill Martin, Chief Medical Officer

Dr. Bill Martin

Chief Medical Officer

MD, MBA, MPH, MMCi

Occupational medicine specialist who co-authored the landmark national LAA study of 141 institutions and 58,224 laboratory workers published in JOEM (2023), providing medical direction for every surveillance assessment.

Animal Exposure Assessment

Evaluation of animal species contact, work tasks, and protective equipment use in laboratory environments

NIOSH Alert Response

Guidance on the NIOSH Alert recommendations for preventing animal-induced asthma and on General Duty Clause obligations

Early Detection Protocol

Proactive surveillance methodology designed to identify at-risk workers before symptom progression to permanent respiratory disability